Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1979-2019Class II

The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the...

Roche Diagnostics GmbH / initiated 2019-06-03 / Terminated / root cause: manufacturing process

Roche Diagnostics Corporation began a recall of The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sample to form an antigen/antibody complex which is... on . FDA classified it as Class II and gives the reason as "Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1979-2019
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Roche Diagnostics GmbH
Product
The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sample to form an antigen/antibody complex which is measured turbidimetrically.
Product code
CZP Iga, Antigen, Antiserum, Control
Reason for recall
Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent.
Root cause tag
manufacturing process
FDA root cause
Material/Component Contamination
Action
Urgent Medical Device Correction notification letters dated 6/3/19 were sent to customers.
Quantity in commerce
8 units
Distribution
The products were distributed to the following US states: AL, IN, and KY.
Product codes and lots
Lot 368756

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1979-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1979-2019Class IITerminatedVoluntary: Firm initiated